Lazzari, R, Cano, MB, Martínez, AR, Bueno, MR, Rovira, MC, Campmany, MP. Vibrio fluvialis cholangitis with bacteremia and refractory septic shock: a case report and review of the literature. INFECTION. 2025; 53(6)DOI:10.1007/s15010-025-02535-7. PMID:40377851. IF:3.600(Q2/3D).

Casares, LD, Pereiro, JE, Fernández, MTT, García, XC, Millet, JP, Solchaga, VP, Elorza, EN, García, JT, de Santiago, AD, Márquez, RL, Gallardo, JFM, Galán, VG, Alonso, MM, Brusola, AG, Rey, RR, García, LA, Herrero, FS, Serrano, RG, Fullola, MG, Díez, MT, Zanon, TT, Portero, MF, García, PA, Lopez, AMS, Aznar, ML, Camprecios, JM, Saborit, N, Montalvá, AS. Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Bmj Open Respiratory Research. 2025; 12(1)DOI:10.1136/bmjresp-2024-002475. PMID:41360613. IF:3.400(Q2/3D).

Martínez-Ysasis, Y, Simonetti, AF, Navarro, F. Megaprosthesis Infection by Bacteroides fragilis in a Patient With Ewing's Sarcoma: A Case Report and Literature Review. Clinical Case Reports. 2025; 13(2)DOI:10.1002/ccr3.70185. PMID:39931721. IF:(Q/D).

Mostaza, JM, Suarez, C, Cepeda, JM, Manzano, L, Sanchez, D, Mascaró J., Maestre Peiro, Ana. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovascular Disorders. 2021; 21(1)DOI:10.1186/s12872-021-02019-0. PMID:34372782. IF:2.174(Q4/8D).